CD166 / Janelia Fluor 549 / praluzatamab

Product Details
Supplier Novus Biologicals, a Bio-Techne brand
Catalog #: NBP3-28283JF549 (View supplier product page)
Size 100 μl
Price $379.00
Antigen CD166
Clone praluzatamab
Host Human
Isotype IgG1
Conjugate Janelia Fluor 549
Target Species Human
Applications FC, ELISA, Functional
Description ALCAM/CD166 Antibody (praluzatamab) [Janelia Fluor® 549]
About CD166 and Janelia Fluor 549
CD166 This gene encodes activated leukocyte cell adhesion molecule (ALCAM), also known as CD166 (cluster of differentiation 166), which is a member of a subfamily of immunoglobulin receptors with five immunoglobulin-like domains (VVC2C2C2) in the extracellular domain. This protein binds to T-cell differentiation antigene CD6, and is implicated in the processes of cell adhesion and migration. Multiple alternatively spliced transcript variants encoding different isoforms have been found. [provided by RefSeq, Aug 2011]
Janelia Fluor 549 Janelia Fluor® 549 was developed at the Janelia Campus of the Howard Hughes Medical Institute but is commercialized by other vendors. The Janelia Fluor®s family is unique in that the fluorophores are cell-permeable and are available in photoactivatable forms. These fluorophores were developed for super-resolution microscopy (STED, PALM and STORM) and live-cell microscopy in the HaloTag and SNAP-tag versions. Janelia Fluor® 549 has an excitation peak at 549 nm and an emission peak at 571 nm.
Citations
Additional
Sources
Reviews & Ratings
Submit a Review

Janelia Fluor 549 Excitation and Emission Spectra